InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Wednesday, 09/07/2022 3:13:08 PM

Wednesday, September 07, 2022 3:13:08 PM

Post# of 381
(OT) From this, ''Dr. Wang commented: "In as little as 10 months since the operation of our new laboratories, not only have we completed several signaling pathway modifications and CAR designs tailored for solid tumors, but also we have made significant progress in the development of innovative manufacturing processes of NK differentiation and expansion.'' https://www.prnewswire.com/news-releases/neukio-biotherapeutics-completed-series-a-1-financing-to-accelerate-discovery-and-development-of-next-generation-cell-therapy-products-301616577.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News